One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v130.suppl_1.651.651
Copy DOI Journal: Blood |  Publication Date: Dec 7, 2017 |
 Citations: 25 |
Affiliation: Karmanos Cancer Institute, The University of Texas MD Anderson Cancer Center, Hospital Costa del Sol, Dana-Farber Cancer Institute, General University Hospital in Prague, Hackensack University Medical Center, Mayo Clinic, Hospital Universitario Puerta de Hierro Majadahonda, Medical University of Vienna, Emory University, BC Cancer Agency, University Hospital Innsbruck, Bristol-Myers Squibb (United States), Institut Català d'OncologiaNivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
